Company profile: Nordic Bioscience
1.1 - Company Overview
Company description
- Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
Products and services
- Biomarker Analysis: Performs blood-based laboratory biomarker analysis for various diseases, running assays to quantify disease activity and support drug development and clinical trials
- Protein Fingerprint Technology: ECM-specific method quantifying extracellular matrix protein fragments released from affected tissues in blood as biomarkers to measure disease activity and enable precision drug development
- GRIPonMASH Diagnostic Platform: AI-based platform enabling early detection and management of Metabolic dysfunction-Associated Steatohepatitis by combining biomarkers with decision support tools
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nordic Bioscience
Altasciences
HQ: Canada
Website
- Description: Provider of early phase contract research services for pharmaceutical and biotechnology companies, including preclinical safety testing; Phase I–II clinical pharmacology; bioanalysis from preclinical to Phase IV (LC-MS/MS and ligand binding assays); formulation, manufacturing, and analytical services; specialized renal and hepatic impairment studies via external partners; and cardiac safety assessment including QT prolongation evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altasciences company profile →
Natural Pharmaceuticals
HQ: Poland
Website
- Description: Provider of science- and technology-driven health offerings focused on the Omega-3 segment; a Norwegian market leader dedicated to raising awareness among Central European consumers of the health benefits of diets rich in fish and marine fatty acids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natural Pharmaceuticals company profile →
Parexel
HQ: United States
Website
- Description: Provider of biopharmaceutical services, including clinical research, medical communications, consulting, commercialization, and advanced technology for pharmaceutical, biotechnology, and medical device industries. Offerings include clinical trial management, RWE and late phase research, market access strategy, regulatory compliance and pharmacovigilance, and advanced analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parexel company profile →
Nelson Labs
HQ: United States
Website
- Description: Provider of microbiological testing and consulting services for MedTech companies, offering analytical lab testing, method development and validation, stability studies, extractables and leachables testing, and support for regulatory submissions, product development, and quality assurance to ensure product safety, efficacy, and compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nelson Labs company profile →
Molecular Medicine
HQ: United States
Website
- Description: Provider of process R&D, process and assay development, clinical manufacturing, fill/finish, and GMP storage services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Medicine company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nordic Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nordic Bioscience
2.2 - Growth funds investing in similar companies to Nordic Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nordic Bioscience
4.2 - Public trading comparable groups for Nordic Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →